Stocktoria
iTonic Holdings Ltd ITOC
iTonic Holdings Ltd (ITOC) earns a Piotroski F-score of 1/9 (weak financial health), with an Altman Z″ in the safe zone. It pays a dividend yielding 0.17% (safety: safe). FY2025 revenue was $523,031 at a -974.7% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
How it ranks in Manufacturing · percentile among 1957 companies
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 1/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · safe zone
| Component | Value |
|---|---|
| Working capital / assets | 0.399 |
| Retained earnings / assets | -0.618 |
| EBIT / assets | -0.57 |
| Equity / liabilities | 8.379 |
Sector peers · similar-size Manufacturing companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| ITOC | iTonic Holdings Ltd | 1/9 | 5.57 | — | — |
| POSC | POSITRON CORP | 2/9 | — | — | — |
| NXL | Nexalin Technology, Inc. | 4/9 | — | — | — |
| GTHP | GUIDED THERAPEUTICS INC | 3/9 | — | — | — |
| ENDV | ENDONOVO THERAPEUTICS, INC. | 3/9 | — | — | — |
| VANI | Vivani Medical, Inc. | 1/9 | -14.41 | — | — |
| HCIL | Hongchang International Co., Ltd | 2/9 | 2.23 | — | — |
About iTonic Holdings Ltd
iTonic Holdings Ltd., a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. The company's proprietary treatment planning system is a radioactive particle implantation, a radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company offers FTTPS, a treatment planning system for treating various malignant tumors, which could determine the target volume, prescription dose, and dose limitation to protect organs at risks and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients. The company was formerly known as Pheton Holdings Ltd and changed its name to iTonic Holdings Ltd. in January 2026. iTonic Holdings Ltd. was founded in 1998 and is headquartered in Beijing, China. iTonic Holdings Ltd. operates as a subsidiary of ZJW (BVI) LTD.
FAQ
Is ITOC financially healthy?
iTonic Holdings Ltd's Piotroski F-score is 1/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the safe zone.
Does ITOC pay a dividend, and is it safe?
Yes. iTonic Holdings Ltd pays a dividend yielding about 0.17% with a -0.2% payout ratio, rated “safe” for safety.
How profitable is ITOC?
In FY2025, iTonic Holdings Ltd had a net margin of -974.7% and a return on equity of -62.7%.
Is ITOC a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on iTonic Holdings Ltd: a Piotroski F-score of 1/9, an Altman Z″ in the safe zone, a dividend yield of 0.17%. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.